AdvisorShares Turns Our Attention to Rare Cancer Research – CYCLE FOR SURVIVAL
According to the National Institutes of Health (NIH), a “rare cancer” is one with a prevalence of fewer than 200,000 affected individuals in the United States. But when you put all of these rare cancer types together, they account for approximately half of all cancer diagnoses. Research on many rare cancers is drastically underfunded, often leaving patients with limited or no treatment options. Memorial Sloan Kettering Cancer Center—the world’s oldest and largest private cancer center—is committed to changing that reality.
Cycle for Survival‘s indoor team cycling events raise funds that are critical for rare cancer research. 100% of every donation to Cycle for Survival is directly allocated to research at Memorial Sloan Kettering Cancer Center within six months of the events. Thanks to the tremendous efforts of participants, donors, and supporters, Cycle for Survival has raised over $80 million for rare cancer research, and funded 100+ clinical trials and research studies.
On Sunday, March 6th from 1:00pm to 5:00pm AdvisorShares very own team, AlphaSquad, will Join the Battle! We are committed to ensuring rare cancer patients get new and better treatment options. Want to know who’s riding? Check out our Team Page here. And, after March 6th, check back for pictures and our reflections on the event!